Is this your company? Get featured or correct your listing →
Recent changes
- Jul 2, 2026Jul 2, 2026Raised $126M extension Crunchbase News
- Jul 2, 2026Jul 2, 2026New investor: Bain Capital Crunchbase News
- Jul 2, 2026Jul 2, 2026New investor: Bristol Myers Squibb Crunchbase News
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2026 | extension | $126M | — | Crunchbase News |
Investors
Latest Pulse
- Jul 2, 2026Crunchbase: The Week's 10 Biggest Funding Rounds, Led by Joulent's $1.75B Energy RaiseCrunchbase News' roundup of the week's 10 biggest funding rounds (June 27-July 2) was led by Houston-based energy infrastructure provider Joulent's $1.75 billion raise from National Grid Ventures, aimed squarely at AI and compute-intensive industries' power needs. Together AI's $800M Series C and Venice AI's $65M unicorn round both placed inside the top 10, alongside biotech, legal-tech, sports and video-AI rounds spanning a genuinely broad set of categories beyond pure frontier-model AI.→
- Jul 1, 2026Bain, CPP and Bristol Myers Add $126M to Beeline's Lupus PipelineBeeline Medicines closed a $126.3 million Series A extension from Bain Capital, CPP Investments and Bristol Myers Squibb, upsizing its total Series A to $426.3 million to fund pivotal development of afimetoran in lupus ahead of a Phase 2 readout expected in.→
Coverage Timeline
newest firstAll Coverage
Related Companies
Beeline Medicines FAQ
Who are Beeline Medicines's investors?
Beeline Medicines's investors include Bain Capital, Bristol Myers Squibb.
Sources & methodologyshow
Where these figures come from
- Crunchbase Newsresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.